Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug

(Institute of Cancer Research) Findings could allow doctors to predict resistance and lead to changes in treatment. New gene editing technique used to unearth mutation linked to resistance to targeted PARP inhibitor treatments. Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment olaparib and other PARP inhibitors.